Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Proponents often stress the opportunity for significant therapeutic outcomes, especially in diseases where conventional treatments have proven limited. However, this is to evaluate the significant financial expenditure associated with CPI stem cell the